4//SEC Filing
Chen Shu-Chih 4
Accession 0001437749-23-012869
CIK 0001488039other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 7:35 PM ET
Size
5.1 KB
Accession
0001437749-23-012869
Insider Transaction Report
Form 4
Chen Shu-Chih
DirectorChief Scientific Officer10% Owner
Transactions
- Award
Stock Option (right to buy)
2023-05-04+125,000→ 125,000 totalExercise: $0.66Exp: 2033-05-04→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The options shall vest on a quarterly basis over the next 12 months. The options were issued at approximately 9:50 a.m. (ET) on May 4, 2023, with an exercise price of $0.662, representing the most recently reported closing stock price on May 3, 2023.
Documents
Issuer
ATOSSA THERAPEUTICS, INC.
CIK 0001488039
Entity typeother
Related Parties
1- filerCIK 0001552127
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 7:35 PM ET
- Size
- 5.1 KB